AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Jakmac-ER Tablet

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Tofacitinib (11mg)

Overview Jakmac-ER Tablet

Extended-release Jakmac tablets are indicated for managing moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. The medication alleviates joint pain, tenderness, and swelling by suppressing inflammation, and it also helps retard the progression of bone and joint deterioration. Jakmac-ER may be administered alone or as part of a combination therapy. These tablets can be ingested with or without food, ideally at the same time daily. Dosage is individualized based on your health status and other medications. Always follow your physician's instructions; abruptly discontinuing treatment may exacerbate your condition. Common adverse effects include upper respiratory infections, headache, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, side effects such as blood clots and gastrointestinal perforations necessitate immediate medical attention. Consult your doctor regarding any concerns about side effects. Pre-treatment bloodwork may be required, and initiation is contraindicated with any active infection. Prior to commencing therapy, inform your physician if you have a history of tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism. Jakmac-ER may increase susceptibility to infections or worsen existing ones; therefore, minimize exposure to contagious illnesses (e.g., varicella, rubeola, influenza). This medication is unsuitable for individuals under 18 years of age and is contraindicated during pregnancy and lactation unless deemed medically necessary by your doctor. Regular monitoring by your physician may be necessary.

Uses of Jakmac-ER Tablet

Management of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.

Major Benefits of Jakmac-ER Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Jakmac-ER Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, however, consistent timing is recommended.

Common Side effects of Jakmac-ER Tablet:

  • Upper respiratory tract infection
  • Headache
  • Diarrhea
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Jakmac-ER Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Jakmac-ER Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.

How Jakmac-ER Tablet works:

Jakmac-ER tablets function as a Janus kinase inhibitor, suppressing Janus kinase enzyme activity. This mechanism reduces immune system responsiveness and inflammation characteristic of rheumatic conditions and ulcerative colitis.

SAFETY ADVICE

AlcoholAlcoholSAFE

Ingesting alcohol alongside Jakmac-ER tablets poses no known adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Jakmac-ER Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Jakmac-ER tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Jakmac-ER Tablet.

KidneyKidneyCAUTION

Patients with severe renal impairment should use Jakmac-ER Tablet judiciously. Dosage modification of Jakmac-ER Tablet may be necessary. Physician consultation is advised.

LiverLiverCAUTION

For individuals with severe hepatic impairment, Jakmac-ER Tablet requires careful administration. Dosage modification of Jakmac-ER Tablet may be necessary. Physician consultation is advised.

What if you forget to take Jakmac-ER Tablet :

Should you forget a Jakmac-ER Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Jakmac-ER Tablet

LabelValue
Chemical Type Pyrrolopyrimidine Compound
Developing Habits No.
Type of Treatment Pain Relievers
Action Class JAK inhibitors

FAQs on Jakmac-ER Tablet

Tell your doctor about any liver problems before taking Jakmac-ER Tablet. This medication may raise liver enzyme levels in some people, so your liver function should be checked beforehand. While Jakmac-ER Tablet can be used for those with mild to moderate liver impairment, it's contraindicated in patients with severe impairment.
Jakmac-ER tablets may increase the risk of certain cancers, such as lymphoma and skin cancer, by impacting the immune system. Therefore, tell your doctor if you have or have ever had cancer.
Jakmac-ER tablets treat moderate to severe rheumatoid arthritis, a joint inflammatory disease. This medication is used when prior treatments proved ineffective or unsuitable. It may also be prescribed early if initial medications fail, and can be used alone or in conjunction with other drugs like methotrexate.
You may begin to feel improvement from Jakmac-ER Tablet within 2 to 8 weeks, with maximum benefits typically seen after 3 to 6 months.
Before and during Jakmac-ER Tablet treatment, blood tests may be necessary. These tests check for anemia, neutropenia or lymphopenia, high cholesterol, and elevated liver enzymes, helping to monitor treatment safety. Your doctor might also recommend a tuberculosis test beforehand, as Jakmac-ER Tablet could exacerbate existing infections.
Jakmac-ER tablets suppress the immune system, increasing susceptibility to serious infections, including tuberculosis and potentially life-threatening disseminated fungal, bacterial, or viral infections. Hospital treatment is necessary for such infections.
Combining tocilizumab and Jakmac-ER Tablet is not recommended. Since Jakmac-ER Tablet weakens the immune system, concurrent use with other immunosuppressants, such as tocilizumab, significantly raises the risk of infection and potential complications.
Jakmac-ER Tablet
259
MRP 300
13% off